Read more

December 16, 2020
1 min watch
Save

Clinicians face challenges in diagnosis, treatment of RCC

Healio spoke with Elizabeth Plimack, MD, chief of the division of genitourinary medical oncology at Fox Chase Cancer Center, about important issues in the diagnosis and treatment of renal cell carcinoma.

Major concerns include detecting RCC earlier, especially during the COVID-19 pandemic, as well as a lack of a proven neoadjuvant strategy for high-risk patients after surgery, she said.

Click here to watch the next video in the series on selecting combination therapies for patients with RCC.